Welcome to an exciting and engaging new podcast series from Science Custom Solutions! In this three-part series, we’ll be talking to prominent bioscientists across a range of research fields about how they’re applying and adapting the latest technologies—in particular the most recent advances in CRISPR-based gene editing—to their area of study.
The first of the three interviewees is Dr. Robin Ketteler from the Laboratory for Molecular Cell Biology Group Leader and High Content Biology Leader at University College London in the United Kingdom. Robin is an expert in cell signaling and autophagy. Next is Dr. Stephen Jackson, professor in the Department of Biochemistry at the Wellcome Trust/Cancer Research UK Gurdon Institute at the University of Cambridge. He studies DNA damage and repair. Our final guest is Dr. Mathias Uhlén from KTH Royal Institute of Technology. His broad focus is protein science and antibody engineering, but this time Mathias will be talking to us specifically about antibody validation.
Future eposides will be released at 2-week intervals.
Our thanks to Horizon Discovery for their kind sponsorship of this webinar series. From research to therapy, Horizon Discovery drives the application of gene editing and gene modulation. Innovative tools and services enable scientists to gain a greater understanding of the genetic drivers behind disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine.